Livzon Pharmaceutical Group Co., Ltd., founded in 1985, is a well-known trademark in Guangdong Province, a listed company integrating pharmaceutical R&D, production and sales, and is well-known in the digestive tract drug/cardiovascular and cerebrovascular drug/anti-infective drug industry

Livzon Pharmaceutical Group Co., Ltd. is a comprehensive enterprise group integrating pharmaceutical R&D, production and sales, founded in January 1985 with a registered capital of 390 million yuan. The group now has 18 patented products and 21 exclusive products, among which Shenqi Fuzheng Injection and Ilaprazole are more famous.

In 2014, Livzon completed the conversion of B to H shares, which was the first in the industry. In 2016, the Group will relocate to Livzon Industrial Park, Jinwan District, which covers an area of 427,000 square meters with a total investment of about 2 billion yuan, and is a world-class modern pharmaceutical production base built in accordance with US FDA and EU standards.

The company is always committed to the cause of human health, providing domestic leading, international first-class specialty drugs, the company is committed to the strategic transformation to biopharmaceuticals, and developing the layout of the field of "precision medicine"! According to the company's development strategy, the company will achieve the sales target of 10 billion yuan by 2017.